Literature DB >> 20392610

Gene expression profiling of suicide completers.

L M Fiori1, G Turecki.   

Abstract

Despite strong evidence for a role of biological factors in the etiology and pathology of suicide, the study of traditional neurotransmitter systems has been able to explain only a small proportion of the neurobiology of what is now recognized as a complex genetic trait. The use of microarrays to simultaneously examine the expression levels of thousands of gene transcripts has vastly expanded our capacity to detect the involvement of additional genes and pathways in suicidality, and has opened many new avenues for the discovery of the biological underpinnings of suicide completion. This review examines microarray studies which have been used to identify genes displaying altered expression in suicide completers, and highlights some of the important methodological considerations and metabolic pathways which have emerged from these analyses. (c) 2010 Elsevier Masson SAS. All rights reserved.

Mesh:

Year:  2010        PMID: 20392610     DOI: 10.1016/j.eurpsy.2009.12.013

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

Review 1.  Neurobiology of suicide: do biomarkers exist?

Authors:  Alessandra Costanza; Isabella D'Orta; Nader Perroud; Sandra Burkhardt; Alain Malafosse; Patrice Mangin; Romano La Harpe
Journal:  Int J Legal Med       Date:  2013-02-22       Impact factor: 2.686

2.  A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder.

Authors:  Honglei Yin; Spiro P Pantazatos; Hanga Galfalvy; Yung-Yu Huang; Gorazd B Rosoklija; Andrew J Dwork; Ainsley Burke; Victoria Arango; Maria A Oquendo; John J Mann
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-19       Impact factor: 3.568

3.  Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide.

Authors:  Spiro P Pantazatos; Stuart J Andrews; Jane Dunning-Broadbent; Jiuhong Pang; Yung-Yu Huang; Victoria Arango; Peter L Nagy; J John Mann
Journal:  Neurobiol Dis       Date:  2015-05-08       Impact factor: 5.996

4.  Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use Disorder.

Authors:  Brenda Cabrera; Nancy Monroy-Jaramillo; Gabriel Rodrigo Fries; Roberto Cuauhtemoc Mendoza-Morales; Fernando García-Dolores; Alejandra Mendoza-Larios; Carlos Diaz-Otañez; Consuelo Walss-Bass; David Colin Glahn; Patricia Ostrosky-Wegman; Cristobal Fresno; Humberto Nicolini
Journal:  Mol Neuropsychiatry       Date:  2018-11-12

5.  Identification of potential blood biomarkers associated with suicide in major depressive disorder.

Authors:  Firoza Mamdani; Matthieu D Weber; Blynn Bunney; Kathleen Burke; Preston Cartagena; David Walsh; Francis S Lee; Jack Barchas; Alan F Schatzberg; Richard M Myers; Stanley J Watson; Huda Akil; Marquis P Vawter; William E Bunney; Adolfo Sequeira
Journal:  Transl Psychiatry       Date:  2022-04-14       Impact factor: 7.989

6.  Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity.

Authors:  S P Pantazatos; Y-Y Huang; G B Rosoklija; A J Dwork; V Arango; J J Mann
Journal:  Mol Psychiatry       Date:  2016-08-16       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.